Final Primary Results from the Defifrance Registry Study: Effectiveness and Safety of Defibrotide in the Treatment of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome after Hematopoietic Cell Transplantation

Mohamad Mohty (1) , Ibrahim Yakoub-Agha (2, 3) , Myriam Labopin (1) , Didier Blaise (4) , Delphine Lebon (5, 6) , Virginie Gandemer (7, 8) , Sebastien Maury (9) , Cecile Renard (10, 11) , Charlotte Jubert (12) , Robert J. Ryan (13) , Virginie Bouvatier (13) , Jean-Hugues Dalle (14, 15, 16) , Regis Peffault de Latour (17)

1 CRSA - Centre de Recherche Saint-Antoine
2 CHRU Lille - Centre Hospitalier Régional Universitaire [Lille]
3 EBMT - Centre International des greffes [CHU Saint-Antoine]
4 CRCM - Centre de Recherche en Cancérologie de Marseille
5 CHU Amiens-Picardie
6 HEMATIM - HEMATIM - Hématopoïèse et immunologie - UR UPJV 4666
7 IGDR - Institut de Génétique et Développement de Rennes
8 CHU Pontchaillou [Rennes]
9 CHU Henri Mondor
10 IHOPe - Institut d'hématologie et d'oncologie pédiatrique [CHU - HCL]
11 UCBL - Université Claude Bernard Lyon 1
12 CHU Bordeaux [Bordeaux]
13 Jazz Pharmaceuticals, Inc
14 UPCité - Université Paris Cité
15 HIPI (UMR_S_976 / U976) - Immunologie humaine, physiopathologie & immunothérapie
16 AP-HP Hôpital universitaire Robert-Debré [Paris]
17 Service d'Hémato-oncologie [CHU Saint-Louis]

Domaines: Sciences du Vivant [q-bio]

Mohamad Mohty, Ibrahim Yakoub-Agha, Myriam Labopin, Didier Blaise, Delphine Lebon, et al.. Final Primary Results from the Defifrance Registry Study: Effectiveness and Safety of Defibrotide in the Treatment of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome after Hematopoietic Cell Transplantation. Blood, 2020, 136 (1), ⟨10.1182/blood-2020-136685⟩. ⟨hal-03606392⟩